The 12 closest competitors and alternatives to Parallel Bio among biotech companies — ranked by similarity to what Parallel Bio actually does, not by market-cap band.
Subscribe to see Parallel Bio’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Parallel Bio provides a human-first drug discovery and precision medicine platform that maps human biology using patient samples and computational tools. The company serves pharmaceutical and biotechnology organizations by conducting faster, animal-free preclinical testing and generating proprietary human biological data.
Parallel Bio is a biotech company. Its most recent funding round, seed stage, raised $21M in June 2025. Xcout tracks 3 named people at Parallel Bio, including Juliana Hilliard (Co-Founder & Co-CEO). Xcout recorded 7 job postings from Parallel Bio in the last 90 days.
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| seed stage | $21M | 8 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Xcout recorded 7 job postings from Parallel Bio in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see Parallel Bio's hiring signals →
Ranked by semantic similarity — how close each company is to Parallel Bio by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotech company
Origin Bio operates a tissue-first data and model platform that maps cancer biology using patient tumor samples. The company generates spatial, molecular, and functional maps from real tumor tissue to support target discovery, drug response prediction, and multimodal AI modeling for researchers and life sciences partners.
Similar biotech company
Variant Bio, Inc. is a biotechnology company that uses human genomic diversity and population genetics to discover therapeutic targets and develop medicines. It works with researchers, healthcare and biotechnology partners, and genetically diverse communities to study traits associated with health and disease.
Similar biotech company
Verge Genomics develops a proprietary AI and machine learning platform utilizing human brain data to transform neuroscience drug discovery and precision neurology. The company provides foundation models and analytical tools to pharmaceutical and biotechnology developers for target discovery, biomarker identification, and clinical trial patient stratification.
Biotechnology
Fauna Bio is a biotechnology company headquartered in Berkeley, California. The company combines animal genomics and advanced data approaches to drive drug discovery and improve human health.
Similar biotech company
Centogene provides precision medicine solutions through advanced diagnostics, multiomic testing, and bioinformatics platforms. The company serves physicians, patients, and pharmaceutical partners by offering genomic sequencing, biomarker testing, and data-driven insights to accelerate rare disease diagnosis, drug discovery, and personalized therapies.
Similar biotech company
Valerio Therapeutics is a biotechnology company that develops precision-guided therapeutics for complex and underserved diseases. It utilizes a proprietary V-Body conjugate platform, based on synthetic single-domain antibody libraries, to enable targeted drug delivery and deep tissue penetration.
Biotechnology
Impact Proteomics provides a proprietary antigen profiling and protein identification platform that analyzes patient samples to map disease-associated antigens without cloned intermediates. The company serves biotechnology and diagnostic partners by enabling target discovery, companion diagnostics development, and therapeutic selection for oncology and autoimmune diseases.
Biotechnology
SwitchPoint Bio Holding, Inc. operates a platform that combines precision epigenomics and artificial intelligence to analyze cellular biology from blood samples. The company provides biomarker discovery, patient stratification, and treatment response mechanism readouts to support drug development and clinical research.
Biotechnology
Tessellate Bio is a biotechnology company that develops precision oncology medicines by exploring synthetic lethal interactions beyond homologous recombination deficiency. The company integrates biomarker discovery and companion diagnostics into its research programs to create first-in-class treatments for hard-to-treat cancers.
Similar biotech company
Indivumed GmbH is a precision oncology company that provides tumor and normal tissue samples, multi-omics and clinical data databases, biomathematical and AI tools, and patient-derived cellular models. The company serves researchers and pharmaceutical partners by conducting cancer target discovery, target validation, and therapeutic drug development.
Healthcare / Biotech
Scipher Medicine Corp. is a biotechnology holding company based in Massachusetts that serves healthcare providers, payers, and pharmaceutical companies. It operates precision medicine platforms to improve drug response and clinical outcomes.
Biotechnology
Portal Biotech is a biotechnology company founded by DNA-sequencing veterans that leverages machine learning and nanopore expertise. The firm has built a specialized platform capable of sequencing full-length proteins at the single-molecule level.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Parallel Bioand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →